United Greeneries (UG), a wholly owned subsidiary of Harvest One Cannabis Inc. (TSXV: HVT), announced on June 18th the company’s acquisition of a dealer’s license. This dealer’s license is from the Controlled Drugs and Substances Act under Health Canada.

This dealer’s license allows United Greeneries to import their products into Canada, including their key Gelpell Microgel cannabidiol (CBD), which is being sold in the European Union as a nutritional supplement and in Australia as a prescription drug.

The license will also allow United Greeneries to export medical cannabis products to other countries with a strong medicinal marijuana market, like Germany.

The company intends to use this license and further their research and development of cannabis products in their product development facility in British Columbia.

Leave a Reply